Literature DB >> 7684764

Interactions of lipopolysaccharide with neutrophils in blood via CD14.

R Weingarten1, L A Sklar, J C Mathison, S Omidi, T Ainsworth, S Simon, R J Ulevitch, P S Tobias.   

Abstract

The functional characteristics of neutrophils are exceedingly sensitive to physiological conditions as well as the details of isolation. Exposure to lipopolysaccharide (LPS) or even contamination of the isolating media with traces of LPS is known to play an important role in regulating cell function and expression of receptors. Because of the suspected role of CD14 as a receptor for LPS, we used anti-CD14 monoclonal antibodies both to identify CD14 in the cell surface of polymorphonuclear leukocytes and to inhibit functional changes elicited by LPS. Cytometric techniques were used to investigate the regulation of CD14 and CR3 on the neutrophil cell surface in whole blood to minimize any effects of isolation. In whole blood neutrophil express low levels of formyl peptide receptor, CD14, and CR3, which increase substantially in response to formyl peptide and LPS. The increases in CR3 and CD14 occurred in parallel and were independent of protein synthesis and tumor necrosis factor (TNF) production. The increase in CR3 was inhibited by antibodies MY4, 3C10, and 28C5 against CD14. These findings are consistent with the notion that in blood the observed receptor up-regulation is in direct response to the action of LPS on neutrophils through CD14 and does not require products from macrophages such as TNF or the production of C5a from the plasma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684764     DOI: 10.1002/jlb.53.5.518

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

1.  Diminished priming of neonatal polymorphonuclear leukocytes by lipopolysaccharide is associated with reduced CD14 expression.

Authors:  G Qing; K Rajaraman; R Bortolussi
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

2.  Role of calcium during lipopolysaccharide stimulation of neutrophils.

Authors:  D A Rodeberg; G F Babcock
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Lipopolysaccharide binding proteins on polymorphonuclear leukocytes: comparison of adult and neonatal cells.

Authors:  G Qing; S Howlett; R Bortolussi
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Influence of polyclonal immunoglobulins on the polymorphonuclear leukocyte response to lipopolysaccharide of Salmonella enteritidis as measured with luminol-enhanced chemiluminescence.

Authors:  D R Wagner; D Heinrich
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

5.  Heterogeneity in Lewis-X and sialyl-Lewis-X antigen expression on monocytes in whole blood: relation to stimulus-induced oxidative burst.

Authors:  C Elbim; J Hakim; M A Gougerot-Pocidalo
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

Review 6.  Innate immunity in triggering and resolution of acute gouty inflammation.

Authors:  David M Rose; Ru Liu-Bryan
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

7.  Role of tumor necrosis factor alpha in induction of murine CD14 gene expression by lipopolysaccharide.

Authors:  C Fearns; D J Loskutoff
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

Review 8.  The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.

Authors:  R R Schumann; E T Rietschel; H Loppnow
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

9.  Transient endotoxemia during burn wound revision causes leukocyte beta 2 integrin up-regulation and cytokine release.

Authors:  O Ljunghusen; S Berg; J Hed; J Lundahl; H Nettelblad; F Sjögren; O Stendahl
Journal:  Inflammation       Date:  1995-08       Impact factor: 4.092

10.  Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants.

Authors:  Mark B Stoddard; Valerian Pinto; Paul B Keiser; Wendell Zollinger
Journal:  Clin Vaccine Immunol       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.